Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest

Neuroscience

Volumn 170, Issue 1, 2010, Pages 214-222

  Stern, C A J ^a   Do Monte, F H M ^a   Gazarini, L ^a   Carobrez, A P ^a   Bertoglio, L J ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Defensive behavior; Emotional memory; Fear conditioning; Medial prefrontal cortex

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; COBALT; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SCOPOLAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARM MOVEMENT; ARTICLE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; LEARNING; LIMBIC CORTEX; MALE; MAZE TEST; MEMORY CONSOLIDATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; EXPLORATORY BEHAVIOR; LIMBIC SYSTEM; MALE; MAZE LEARNING; PREFRONTAL CORTEX; RATS; RATS, WISTAR; TIME FACTORS;

EID: 77955926365     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.080     Document Type: Article

References (56)

1. Albrechet-Souza L., Borelli K.G., Brandão M.L. Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze. J Neurosci Methods 2008, 169:109-118.
2. Albrechet-Souza L., Borelli K.G., Carvalho M.C., Brandão M.L. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity. Neuroscience 2009, 164:387-397.
3. Anglada-Figueroa D., Quirk G.J. Lesions of the basal amygdala block expression of conditioned fear but not extinction. J Neurosci 2005, 25:9680-9685.
4. Bertoglio L.J., Carobrez A.P. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav Brain Res 2000, 108:197-203.
5. Bertoglio L.J., Carobrez A.P. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Psychopharmacology 2003, 170:335-342.
6. Bertoglio L.J., Carobrez A.P. Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behav Pharmacol 2004, 15:45-54.
7. Bertoglio L.J., Joca S.R., Guimarães F.S. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res 2006, 175:183-188.
8. Bertoglio L.J., Zangrossi H. Involvement of dorsolateral periaqueductal gray N-methyl-D-aspartic acid glutamate receptors in the regulation of risk assessment and inhibitory avoidance behaviors in the rat elevated T-maze. Behav Pharmacol 2006, 17:589-596.
9. Blanchard D.C., Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J Comp Physiol Psychol 1972, 81:281-290.
10. Blum S., Hebert A.E., Dash P.K. A role for the prefrontal cortex in recall of recent and remote memories. Neuroreport 2006, 17:341-344.
11. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 2005, 29:1193-1205.
12. Corcoran K.A., Quirk G.J. Activity in prelimbic cortex is necessary for the expression of learned, but not innate, fears. J Neurosci 2007, 27:840-844.
13. Cousens G., Otto T. Both pre- and posttraining excitotoxic lesions of the basolateral amygdala abolish the expression of olfactory and contextual fear conditioning. Behav Neurosci 1998, 112:1092-1103.
14. Do Monte F.H., Canteras N.S., Fernandes D., Assreuy J., Carobrez A.P. New perspectives on beta-adrenergic mediation of innate and learned fear responses to predator odor. J Neurosci 2008, 28:13296-13302.
15. Duncan G.E., Knapp D.J., Breese G.R. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res 1996, 713:79-91.
16. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav 1996, 54:31-40.
17. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 1993, 58:199-202.
18. File S.E., Mabbutt P.S., Hitchcott P.K. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology 1990, 102:98-101.
19. Gonzalez L.E., Rujano M., Tucci S., Paredes D., Silva E., Alba G., Hernandez L. Medial prefrontal transection enhances social interaction. I: behavioral studies. Brain Res 2000, 887:7-15.
20. Goosens K.A., Maren S. Contextual and auditory fear conditioning are mediated by the lateral, basal, and central amygdaloid nuclei in rats. Learn Mem 2001, 8:148-155.
21. Helmstetter F.J., Bellgowan P.S. Effects of muscimol applied to the basolateral amygdala on acquisition and expression of contextual fear conditioning in rats. Behav Neurosci 1994, 108:1005-1009.
22. Holmes A., Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?. Pharmacol Biochem Behav 1998, 60:473-488.
23. Hughes R.N., Desmond C.S., Fisher L.C. Room novelty, sex, scopolamine and their interactions as determinants of general activity and rearing, and light-dark preferences in rats. Behav Processes 2004, 67:173-181.
24. Jinks A.L., McGregor I.S. Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res 1997, 772:181-190.
25. Kim M., Davis M. Electrolytic lesions of the amygdala block acquisition and expression of fear-potentiated startle even with extensive training but do not prevent reacquisition. Behav Neurosci 1993, 107:580-595.
26. Kim J.J., Jung M.W. Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review. Neurosci Biobehav Rev 2006, 30:188-202.
27. Kincheski G.C., Carobrez A.P. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze. Behav Brain Res 2010, 206:120-126.
28. Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 2010, 34:1307-1350.
29. Kretz R. Local cobalt injection: a method to discriminate presynaptic axonal from postsynaptic neuronal activity. J Neurosci Methods 1984, 11:129-135.
30. Kroon J.A., Carobrez A.P. Olfactory fear conditioning paradigm in rats: effects of midazolam, propranolol or scopolamine. Neurobiol Learn Mem 2009, 91:32-40.
31. Lacroix L., Broersen L.M., Weiner I., Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience 1998, 84:431-442.
32. Lamprea M.R., Cardenas F.P., Silveira R., Morato S., Walsh T.J. Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms. Behav Brain Res 2000, 117:97-105.
33. Lee C., Rodgers R.J. Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology 1990, 102:507-513.
34. Lomber S.G. The advantages and limitations of permanent or reversible deactivation techniques in the assessment of neural function. J Neurosci Methods 1999, 86:109-117.
35. Maren S. Neurobiology of Pavlovian fear conditioning. Annu Rev Neurosci 2001, 24:897-931.
36. Matus-Amat P., Higgins E.A., Barrientos R.M., Rudy J.W. The role of the dorsal hippocampus in the acquisition and retrieval of context memory representations. J Neurosci 2004, 24:2431-2439.
37. McNaughton N., Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci Biobehav Rev 2004, 28:285-305.
38. Morgan M.A., Romanski L.M., LeDoux J.E. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett 1993, 163:109-113.
39. Nascimento Häckl L.P., Carobrez A.P. Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats. Neurobiol Learn Mem 2007, 88:177-185.
40. Paré D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. J Neurophysiol 2004, 92:1-9.
41. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2009, Academic Press, San Diego, CA. Compact 6th ed.
42. Resstel L.B., Souza R.F., Guimarães F.S. Anxiolytic-like effects induced by medial prefrontal cortex inhibition in rats submitted to the Vogel conflict test. Physiol Behav 2008, 93:200-205.
43. Rodgers R.J., Cao B.J., Dalvi A., Holmes A. Animal models of anxiety: an ethological perspective. Braz J Med Biol Res 1997, 30:289-304.
44. Rodgers R.J., Johnson N.J., Cole J.C., Dewar C.V., Kidd G.R., Kimpson P.H. Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade. Pharmacol Biochem Behav 1996, 54:41-50.
45. Sanders M.J., Wiltgen B.J., Fanselow M.S. The place of the hippocampus in fear conditioning. Eur J Pharmacol 2003, 463:217-223.
46. Schafe G.E., Nader K., Blair H.T., LeDoux J.E. Memory consolidation of Pavlovian fear conditioning: a cellular and molecular perspective. Trends Neurosci 2001, 24:540-546.
47. Shah A.A., Sjovold T., Treit D. Inactivation of the medial prefrontal cortex with the GABAA receptor agonist muscimol increases open-arm activity in the elevated plus-maze and attenuates shock-probe burying in rats. Brain Res 2004, 1028:112-115.
48. Shah A.A., Treit D. Excitotoxic lesions of the medial prefrontal cortex attenuate fear responses in the elevated-plus maze, social interaction and shock probe burying tests. Brain Res 2003, 969:183-194.
49. Sierra-Mercado D., Corcoran K.A., Lebrón-Milad K., Quirk G.J. Inactivation of the ventromedial prefrontal cortex reduces expression of conditioned fear and impairs subsequent recall of extinction. Eur J Neurosci 2006, 24:1751-1758.
50. Smythe J.W., Murphy D., Bhatnagar S., Timothy C., Costall B. Muscarinic antagonists are anxiogenic in rats tested in the black-white box. Pharmacol Biochem Behav 1996, 54:57-63.
51. Staples L.G., McGregor I.S., Apfelbach R., Hunt G.E. Cat odor, but not trimethylthiazoline (fox odor), activates accessory olfactory and defense-related brain regions in rats. Neuroscience 2008, 151:937-947.
52. Stern C.A., Carobrez A.P., Bertoglio L.J. Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze. Pharmacol Biochem Behav 2008, 90:545-550.
53. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 1993, 44:463-469.
54. Vargas K.M., Da Cunha C., Andreatini R. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1394-1402.
55. Wall P.M., Messier C. Concurrent modulation of anxiety and memory. Behav Brain Res 2000, 109:229-241.
56. Wilensky A.E., Schafe G.E., Kristensen M.P., LeDoux J.E. Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J Neurosci 2006, 26:12387-12396.